Epigenetic reader domain inhibitor BRD-IN-3, Purity ≥98%

Synonym: 2351938-32-2; BRD-IN-3; CHEMBL4574669; 2-{[(3R,5R)-5-(2,3-dihydro-1,4-benzodioxin-6-yl)-1-methylpiperidin-3-yl]amino}-3-methyl-3,5-dihydro-4H-pyrrolo[3,2-d]pyrimidin-4-one; BDBM50512964; Epigenetic reader domain inhibitor

CAS Number: 2351938-32-2
Compound CID: 138105961

Product Size

5 mg; 10 mg; 50 mg

Price

Datasheet

MSDS

Properties

Description

BRD-IN-3 disrupts the function of proteins that recognize and bind specific epigenetic marks, affecting the interpretation of epigenetic signals.

Molecular Weight

395.45

Molecular Formula

C₂₁H₂₅N₅O₃

Form

Lyophilized powder

Purity

Identity

Confirmed by NMR/HPLC/MS.

Applications

BRD-IN-3 can be used to study the inhibition of bromodomain-containing proteins, contributing to the understanding of epigenetic regulation and cancer.